Literature DB >> 18718357

The neuroanatomical basis of slow saccades in spinocerebellar ataxia type 2 (Wadia-subtype).

S Geiner1, A K E Horn, N H Wadia, H Sakai, J A Büttner-Ennever.   

Abstract

In a case of spinocerebellar ataxia type 2, Wadia-subtype (SCA2), with slow horizontal saccades, we used parvalbumin immunohistochemistry to identify the omnipause (OPNs) excitatory (EBNs), and inhibitory burst neurons (IBNs) of the saccade generator. Nissl sections was used to measure neuronal diameters, and synaptophysin staining to estimate of synaptic density on the cell somata. Morphometric and synaptic density measurements of the abducens motoneurons were identical in SCA2 and the control. A significant cell loss and reduced synaptic density on somata was found only in the EBN area. We conclude that degeneration of the EBNs is the most likely cause for the slowing of horizontal saccades.

Entities:  

Mesh:

Year:  2008        PMID: 18718357     DOI: 10.1016/S0079-6123(08)00683-3

Source DB:  PubMed          Journal:  Prog Brain Res        ISSN: 0079-6123            Impact factor:   2.453


  14 in total

Review 1.  Saccadic palsy following cardiac surgery: a review and new hypothesis.

Authors:  Scott D Z Eggers; Anja K E Horn; Sigrun Roeber; Wolfgang Härtig; Govind Nair; Daniel S Reich; R John Leigh
Journal:  Ann N Y Acad Sci       Date:  2015-02-26       Impact factor: 5.691

2.  Functional consequences of oculomotor disorders in hereditary cerebellar ataxias.

Authors:  M F Alexandre; S Rivaud-Péchoux; G Challe; A Durr; B Gaymard
Journal:  Cerebellum       Date:  2013-06       Impact factor: 3.847

3.  Clinical evaluation of eye movements in spinocerebellar ataxias: a prospective multicenter study.

Authors:  M Moscovich; Michael S Okun; Chris Favilla; Karla P Figueroa; Stefan M Pulst; Susan Perlman; George Wilmot; Christopher Gomez; Jeremy Schmahmann; Henry Paulson; Vikram Shakkottai; Sarah Ying; Theresa Zesiewicz; S H Kuo; P Mazzoni; Khalaf Bushara; Guangbin Xia; Tetsuo Ashizawa; S H Subramony
Journal:  J Neuroophthalmol       Date:  2015-03       Impact factor: 3.042

4.  Abnormal Findings in Polysomnographic Recordings of Patients with Spinocerebellar Ataxia Type 2 (SCA2).

Authors:  Alessandra Zanatta; Carlos Henrique Ferreira Camargo; Francisco Manoel Branco Germiniani; Salmo Raskin; Ana Chrystina de Souza Crippa; Hélio Afonso Ghizoni Teive
Journal:  Cerebellum       Date:  2019-04       Impact factor: 3.847

5.  A comprehensive clinical and genetic study of a large Mexican population with spinocerebellar ataxia type 7.

Authors:  L Velázquez-Pérez; C M Cerecedo-Zapata; O Hernández-Hernández; E Martínez-Cruz; Y S Tapia-Guerrero; R González-Piña; J Salas-Vargas; R Rodríguez-Labrada; R Gurrola-Betancourth; N Leyva-García; B Cisneros; J J Magaña
Journal:  Neurogenetics       Date:  2014-10-16       Impact factor: 2.660

Review 6.  Spinocerebellar ataxia type 2: clinical presentation, molecular mechanisms, and therapeutic perspectives.

Authors:  J J Magaña; L Velázquez-Pérez; B Cisneros
Journal:  Mol Neurobiol       Date:  2012-09-21       Impact factor: 5.590

Review 7.  A comprehensive review of spinocerebellar ataxia type 2 in Cuba.

Authors:  Luis Velázquez-Pérez; Roberto Rodríguez-Labrada; Julio Cesar García-Rodríguez; Luis Enrique Almaguer-Mederos; Tania Cruz-Mariño; José Miguel Laffita-Mesa
Journal:  Cerebellum       Date:  2011-06       Impact factor: 3.847

Review 8.  Eye Movement Disorders in Movement Disorders.

Authors:  Panagiotis Kassavetis; Diego Kaski; Tim Anderson; Mark Hallett
Journal:  Mov Disord Clin Pract       Date:  2022-02-16

Review 9.  Eye movements in patients with neurodegenerative disorders.

Authors:  Tim J Anderson; Michael R MacAskill
Journal:  Nat Rev Neurol       Date:  2013-01-22       Impact factor: 42.937

10.  Saccadic Palsy following Cardiac Surgery: Possible Role of Perineuronal Nets.

Authors:  Scott D Z Eggers; Anja K E Horn; Sigrun Roeber; Wolfgang Härtig; Govind Nair; Daniel S Reich; R John Leigh
Journal:  PLoS One       Date:  2015-07-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.